Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 11Phase NA 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 1

Status

Completed 13Unknown 10Terminated 4Recruiting 4Active not recruiting 4Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Leukemia, Myeloid, Acute 27Colorectal Neoplasms 27Neoplasms 26Neoplasm Metastasis 22Recurrence 21Multiple Myeloma 20Advanced Solid Tumors 20Lymphoma, B-Cell 19Breast Neoplasms 18Pancreatic Neoplasms 14Lung Neoplasms 13Glioblastoma 13Carcinoma, Hepatocellular 13Lymphoma 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hematologic Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Melanoma 10Leukemia 10Advanced Solid Tumor 10Triple Negative Breast Neoplasms 9Prostatic Neoplasms 9Head and Neck Neoplasms 9Lymphoma, Non-Hodgkin 8Esophageal Neoplasms 8Myelodysplastic Syndromes 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Nasopharyngeal Carcinoma × Clear all
NCT06383507 2024-04-25

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors

Zhejiang University

Phase 1 Not yet recruiting
18 enrolled
GenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡